{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T17:02:27Z","timestamp":1777914147819,"version":"3.51.4"},"reference-count":35,"publisher":"SAGE Publications","issue":"8","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Toxicol Pathol"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:p>Changing the physical state from crystalline to amorphous is an elegant method to increase the bioavailability of poorly soluble new chemical entity (NCE) drug candidates. Subsequently, we report findings from repeat-dose toxicity studies of an NCE formulated as a spray-dried amorphous solid dispersion (SD-ASD) based on hydroxypropyl methylcellulose acetate succinate (HPMC-AS) in rats. At necropsy, agglomerates of SD-ASD were found in the stomach and small intestine, which in reference to literature were termed pharmacobezoars. We interpreted the pH-dependent insolubility of HPMC-AS in the acidic gastric environment to be a precondition for pharmacobezoar formation. Gastric pharmacobezoars were not associated with clinical signs or alterations of clinical pathology parameters. Pharmacobezoar-correlated histopathological findings were limited to the stomach and consisted of atrophy, erosion, ulcer, and inflammation, predominantly of the nonglandular mucosa. Pharmacobezoars in the small intestines induced obstructive ileus with overt clinical signs which required unscheduled euthanasia, prominent alterations of clinical pathology parameters indicative of hypotonic dehydration, degenerative and inflammatory processes in the gastrointestinal tract, and secondary renal findings. The incidence of pharmacobezoars increased with dose and duration of dosing. Besides the relevance of pharmacobezoars to animal welfare, they limit the non-observed adverse effect level in nonclinical testing programs and conclusively their informative value.<\/jats:p>","DOI":"10.1177\/01926233221145112","type":"journal-article","created":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T07:51:44Z","timestamp":1671609104000},"page":"920-929","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":3,"title":["Pharmacobezoar Formation From HPMC-AS-Containing Spray-Dried Formulations in Nonclinical Safety Studies in Rats"],"prefix":"10.1177","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4639-0425","authenticated-orcid":false,"given":"Hannes","family":"Gierke","sequence":"first","affiliation":[{"name":"University of Greifswald, Greifswald, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Pfrommer","sequence":"additional","affiliation":[{"name":"Boehringer Ingelheim Pharma GmbH &amp; Co. KG, Biberach, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kerstin","family":"Sch\u00e4fer","sequence":"additional","affiliation":[{"name":"Boehringer Ingelheim Pharma GmbH &amp; Co. KG, Biberach, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Werner","family":"Weitschies","sequence":"additional","affiliation":[{"name":"University of Greifswald, Greifswald, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9722-0146","authenticated-orcid":false,"given":"Thomas","family":"Nolte","sequence":"additional","affiliation":[{"name":"Boehringer Ingelheim Pharma GmbH &amp; Co. KG, Biberach, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2022,12,21]]},"reference":[{"key":"e_1_3_3_2_2","unstructured":"International Council on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. ICH M3 (R2)\u2014non-clinical safety studies for the conduct of human clinical trials and marketing authorisation for pharmaceuticals. Published 2009. Accessed December 3 2022. https:\/\/database.ich.org\/sites\/default\/files\/M3_R2__Presentation.pdf."},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.2042-7158.2010.01030.x."},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2011.08.032."},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/jps.24541."},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-014-0156-1."},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-010-9431-y."},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-009-9852-z."},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2011.03.024."},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1021\/mp300104s."},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2014.03.018."},{"key":"e_1_3_3_12_2","unstructured":"Shin-Etsu AQOAT\u00ae. Hypromellose Acetate Succinate. Date unknown. Accessed December 3 2022. https:\/\/www.setylose.com\/en\/products\/healthcare\/shinetsu-aqoat."},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1021\/mp8000793"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1258\/002367787781268693."},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1211\/jpp.60.1.0008."},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vascn.2006.02.006."},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.2131\/jts.10.SupplementII_203"},{"key":"e_1_3_3_18_2","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2131\/jts.10.SupplementII_187","article-title":"Studies of hydroxypropylmethylcellulose acetate succinate on fertility in rats","volume":"10","author":"Hoshi N","year":"1985","unstructured":"Hoshi N, Ueno K, Igarashi T, et al. Studies of hydroxypropylmethylcellulose acetate succinate on fertility in rats. J Toxicol Sci. 1985;10(suppl 2):187-201.","journal-title":"J Toxicol Sci"},{"key":"e_1_3_3_19_2","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2131\/jts.10.SupplementII_147","article-title":"Toxicological studies of hydroxypropylmethylcellulose acetate succinate","volume":"10","author":"Hoshi N","year":"1985","unstructured":"Hoshi N, Yano H, Hirashima K, Kitagawa H, Fukuda Y. Toxicological studies of hydroxypropylmethylcellulose acetate succinate. J Toxicol Sci. 1985;10(suppl 2):147-185.","journal-title":"J Toxicol Sci"},{"key":"e_1_3_3_20_2","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2131\/jts.10.SupplementII_129","article-title":"General pharamcological studies of hydroxypropylmethylcellulose acetate succinate in experimental animals","volume":"10","author":"Hoshi N","year":"1985","unstructured":"Hoshi N, Ueno K, Yano H, Hirashima K, Kitagawa H. General pharamcological studies of hydroxypropylmethylcellulose acetate succinate in experimental animals. J Toxicol Sci. 1985;10(suppl 2):129-146.","journal-title":"J Toxicol Sci"},{"key":"e_1_3_3_21_2","doi-asserted-by":"crossref","first-page":"235","DOI":"10.2131\/jts.10.SupplementII_235","article-title":"Effects on offspring induced by oral administration of hydroxypropylmethylcellulose acetate succinate to the female rats in peri- and post-natal periods","volume":"10","author":"Hoshi N","year":"1985","unstructured":"Hoshi N, Ueno K, Igarashi T, et al. Effects on offspring induced by oral administration of hydroxypropylmethylcellulose acetate succinate to the female rats in peri- and post-natal periods. J Toxicol Sci. 1985;10(suppl 2):235-255.","journal-title":"J Toxicol Sci"},{"key":"e_1_3_3_22_2","unstructured":"US Food and Drug Administration. GRAS notice inventory. Published 2020. Accessed December 3 2022. https:\/\/www.fda.gov\/food\/generally-recognized-safe-gras\/gras-notice-inventory."},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1345\/aph.17420."},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.3109\/15563650.2011.559472."},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1159\/000171515"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2017.11.286."},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v11.i12.1813."},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.22456\/1679-9216.85862."},{"issue":"1173","key":"e_1_3_3_29_2","article-title":"An unusual cause of gastrointestinal obstruction: bezoar","volume":"116","author":"Acar T","year":"2003","unstructured":"Acar T, Tuncal S, Aydin R. An unusual cause of gastrointestinal obstruction: bezoar. N Z Med J. 2003;116(1173):U422.","journal-title":"N Z Med J"},{"issue":"3","key":"e_1_3_3_30_2","first-page":"285","article-title":"Intestinal obstruction and bezoars","volume":"179","author":"Escamilla C","year":"1994","unstructured":"Escamilla C, Robles-Campos R, Parrilla-Paricio P, Lujan-Mompean J, Liron-Ruiz R, Torralba-Martinez J. Intestinal obstruction and bezoars. J Am Coll Surg. 1994;179(3):285-288.","journal-title":"J Am Coll Surg"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2022.07.010."},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.1988.255.2.g242."},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2015.00088."},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1002\/bdd.1828."},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.CCM.0000181525.99295.8F."},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1995.tb15935.x."}],"container-title":["Toxicologic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/01926233221145112","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/01926233221145112","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/01926233221145112","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T16:42:57Z","timestamp":1777653777000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/01926233221145112"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":35,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["10.1177\/01926233221145112"],"URL":"https:\/\/doi.org\/10.1177\/01926233221145112","relation":{},"ISSN":["0192-6233","1533-1601"],"issn-type":[{"value":"0192-6233","type":"print"},{"value":"1533-1601","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12]]}}}